News

Welcome to the Investing News Network's weekly look at the best-performing Canadian mining stocks on the TSX, TSXV and CSE, ...
CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on anti-cancer therapies, announced today that a poster presentation of preclinical data of CS2009 ...
The Indian government is refining biosimilar drug regulations, aligning with global standards to ensure stringent quality in ...
(Sharecast News) - Oracle Power announced further encouraging assay results from its ongoing drilling programme at the Northern Zone Intrusive Hosted Gold Project on Wednesday, located near ...
The introduction of commercially available reversed-phase (RP) columns that have stationary phases deliberately doped with ...
Q1 2025 Earnings Call Transcript May 9, 2025 Kymera Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.82, expectations were $-0.92. Justine Koenigsberg: Good morning, and welcome to ...
Ooops... Something went wrong while loading this page.
Q1 2025 Earnings Conference Call May 9, 2025 10:00 AM ETCompany ParticipantsJustine Koenigsberg - Vice President ...
. Introduction: By depleting autoreactive B cells, CD19-targeted CAR-T have shown early yet promising efficacy in treating patients with B cell-driven autoimmune diseases. However, the clinical ...
One can assay the effects of a compound on other members ... have many drawbacks as pharmaceutical agents, their reliable PK properties (and high affinity and selectivity, of course) make them ...